Literature DB >> 656136

Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein.

O G Nilsen, P Leren, I Aakesson, S Jacobsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656136     DOI: 10.1016/0006-2952(78)90411-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  18 in total

1.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

2.  Pharmacokinetics of quinidine related to plasma protein binding in man.

Authors:  D Fremstad; O G Nilsen; L Storstein; J Amlie; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

3.  Lidocaine protein binding in preeclampsia.

Authors:  M B Bottorff; J A Pieper; B A Boucher; T J Hoon; J Ramanathan; B M Sibai
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

5.  Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

6.  Sex-related differences in the plasma protein binding of lignocaine and diazepam.

Authors:  P A Routledge; W W Stargel; B B Kitchell; A Barchowsky; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of quinidine.

Authors:  H R Ochs; D J Greenblatt; E Woo
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

8.  Lignocaine disposition in blood in epilepsy.

Authors:  P A Routledge; W W Stargel; A L Finn; A Barchowsky; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.

Authors:  E Pike; P Kierulf; B Skuterud; J E Bredesen; P K Lunde
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

10.  Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.

Authors:  D L Goolkasian; R L Slaughter; D J Edwards; D Lalka
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.